Centro de Investigación y Gastroenterología

Cuauhtémoc 6700

1 studies enrolling now · 4 studies all time

What they study most

Chronic Kidney Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Obesity, Overweight, T2D, Type 2 Diabetes

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes — Running, not enrolling
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed